Telemonitoring in Patients With Heart Failure
Not Applicable
Completed
- Conditions
- Heart Failure, Congestive
- Interventions
- Device: Telemonitoring in patients with heart failureDevice: Health Buddy system
- Registration Number
- NCT00502255
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
The purpose of this study is to investigate if telemonitoring results in a decrease in hospital admissions, with equal quality of care defined as mortality, quality of life and unplanned visits with caregivers. Telemonitoring is expected to be more cost-effective than usual care in patients with heart failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 382
Inclusion Criteria
- Patients > 18 years
- Patients with heart failure NYHA classification II-III-IV
- Patient experienced a period of fluid retention
- Patient is treated by a cardiologist
- Patient is followed-up by a heart failure nurse
- Adequate knowledge of the Dutch language
- Patient has an active telephone connection, preferably analogue
- Patient is mental competent
- Patient has the disposal of a balance
Exclusion Criteria
- Patients suffering from COPD, Gold classification 3 or 4
- Patient is a dialysis patient
- Patient has a visual restriction to read the dialogues on the Health Buddy
- Patient is hard of hearing or deaf
- Patient suffers from a lethal sickness with a prognosis < 1 year
- Patient participates in another trial
- Patient needs a hospital admission on short time, i.e., < 3 months
- Patient used the Health Buddy in an earlier stage
- Patient is an illiterate person.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description usual care Telemonitoring in patients with heart failure patients receive care as usual telemonitoring Health Buddy system Health Buddy in patients home situation
- Primary Outcome Measures
Name Time Method To what extent will the amount of planned contacts decrease without an increase of unplanned contacts? one year To what extent does the use of Health Buddy result in a decrease in hospital admissions? one year To what extent is Health Buddy® more cost-effective than usual care? one year
- Secondary Outcome Measures
Name Time Method What is the effect of Health Buddy® in patients with heart failure in regard to drug consumption and therapy compliance and level of knowledge, and quality of life? one year To what extent is it - based on patients' characteristics - possible to identify patient with benefits? one year
Trial Locations
- Locations (3)
Atrium Medische Centrum
🇳🇱Heerlen, Limburg, Netherlands
Orbis Medische en Zorgconcern
🇳🇱Sittard, Limburg, Netherlands
Maastricht University Hospital
🇳🇱Maastricht, Limburg, Netherlands